Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
121,543,157
-
Total 13F shares
-
13,374,829
-
Share change
-
-589,791
-
Total reported value
-
$88,003,000
-
Price per share
-
$6.58
-
Number of holders
-
12
-
Value change
-
-$1,315,819
-
Number of buys
-
6
-
Number of sells
-
10
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q2 2020
As of 30 Jun 2020,
Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,374,829 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, FMR LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, BANCO BILBAO VIZCAYA ARGENTARIA, S.A., GEODE CAPITAL MANAGEMENT, LLC, CANADA PENSION PLAN INVESTMENT BOARD, and BlackRock Inc..
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.